The weight-reducing property of molindone, a recently introduced
antipsychotic drug, was tested in 9 hospitalized chronic schizophrenic
patients. There was an average weight loss of 7.6 kg after 3 months on
molindone; most of the loss occurred during the first month. The mechanism
producing this weight loss is uncertain, but a central anorexigenic effect
may be an important factor.